Why Kazakhstan’s Uranium Reliability Is No Longer a Safe Assumption

US utilities recorded a weighted average purchase price of $58.46 per pound for Kazakh uranium across 2025. The spot price on 21 August 2026 sat at $89.50. That 35% gap is not a forecast or a modelling assumption. It is the replacement cost of a disruption to the single largest non-Canadian source of American nuclear fuel.

According to the EIA’s 2025 Uranium Marketing Annual Report, Kazakhstan accounts for 28% of all uranium tonnage delivered to American reactors, placing it second only to Canada and making it the structural anchor of the American nuclear fuel supply chain. Three concurrent developments are quietly eroding the reliability of that position: production costs rising faster than uranium prices, a repeatedly delayed sulfuric acid plant, and a pending shareholder vote that would allocate more supply to Chinese and Russian buyers.

What follows is a precise breakdown of which risks are structural and durable versus which are manageable in the near term, and what that distinction means for anyone assessing Kazakhstani supply as a long-term input for US nuclear generation.

Why Kazatomprom’s cost surge is a structural problem, not a market blip

Kazatomprom’s C1 cash costs rose 37% year-on-year to $24.48 per pound in H1 2026. All-in sustaining costs (AISC), which capture the full expense of maintaining production, climbed 25% to $38.45 per pound over the same period.

The average weekly uranium spot price during H1 2026 was $85.98 per pound, up 24% year-on-year. That means C1 cost inflation exceeded the spot price increase by approximately 13 percentage points.

Direct production costs are expanding roughly 13 percentage points faster than the uranium price benchmark. Even against a backdrop of strong commodity prices, the company’s unit economics are weakening in relative terms.

This is not a single-quarter anomaly. C1 costs ran at approximately $10.25 per pound in 2022 and $17.00-$18.50 per pound in 2025. Full-year 2026 C1 guidance has been revised upward to $25.50-$27.00 per pound (from $23.50-$25.00), and AISC guidance now sits at $39.00-$40.50 per pound (from $35.00-$36.50).

Separating the durable from the manageable

The primary structural driver is Kazakhstan’s mineral extraction tax (MET), which increased from 9% to 12.4%. This is a legislative change with no reversal in any near-term planning horizon. Tenge appreciation against the US dollar compounds the effect, compressing margins when reported in dollar terms.

Sulfuric acid pricing, by contrast, sits in a different category. Management has stated it does not expect a material increase in Kazakh sulfuric acid prices in the near term. Acid accounts for approximately 15.3% of production costs, roughly unchanged year-on-year, which supports the view that it is a manageable cyclical input, not the force driving margin compression.

The distinction matters. Cost-focused investors who track headline revenue growth (up 9% year-on-year in H1 2026) will see a company that appears to be thriving. The margin compression embedded in these numbers tells a different story, and the dominant driver is a tax change that is not going away.

The mineral extraction tax increase, from 9% to 12.4%, sits within a broader pattern of resource nationalism in Kazakhstan that has progressively tightened state leverage over foreign-linked uranium ventures since 2024, a trajectory that investors in Western-aligned producers need to weigh against any near-term cost stabilisation that Kazatomprom reports.

The TQZ acid plant delay compounds an already fragile input chain

Sulfuric acid is a required reagent for in-situ recovery (ISR) extraction, the leaching method Kazatomprom uses across its operations. Without sufficient supply, mining activity is directly constrained. The TQZ sulfuric acid plant was intended to reduce dependence on external sourcing.

That plant has now missed its commissioning target twice, and a third delay is underway.

1. Original target: 2026 commissioning. The plant was designed to bring acid supply in-house and reduce cost volatility.
2. First revision: Q1 2027. Pushed back due to restructuring procedures and delays in approving project design documentation.
3. Current revision: Q3 2027 to Q1 2028. Work on site was halted after earthworks unearthed materials potentially of palaeontological or archaeological significance, obliging the project to comply with mandatory heritage assessment procedures prescribed under Kazakhstani law.

The cumulative overrun is now 12-24 months from the original target. Each delay has arrived from a different cause, which tells you something about the operating environment: the risks to Kazakh infrastructure projects are not concentrated in one predictable category but distributed across regulatory, procedural, and heritage domains.

Management has stated that the TQZ delay is not expected to have a “material” impact on overall mining operations, and that near-term sulfuric acid supply contracts are in place, with coverage typically secured by October.

That position may hold in the near term. But for a Western utility assessing a multi-year Kazakhstani supply contract, a project with two successive commissioning failures and a new regulatory hold is not a scheduling inconvenience. It is evidence that Kazakh operational execution carries procedural risks that cannot be fully modelled in advance.

What Kazakhstan uranium supply risk actually looks like for US utilities

Supply concentration is often discussed in abstract terms. The arithmetic makes it concrete.

The EIA’s 2025 Uranium Marketing Annual Report shows that just three countries together accounted for 75% of all uranium delivered to American nuclear utilities in 2025.

The DOE nuclear fuel supply chain consortium initiative, launched under the Defense Production Act, reflects the federal government’s recognition that import dependence on a small number of foreign uranium suppliers represents a national energy security exposure, not merely a commercial procurement question.

The Kazakhstani portion, representing 28% of deliveries, carries the greatest replacement-cost exposure of any single non-Canadian origin. American reactors contracted at a weighted average of $58.46 per pound across 2025, a figure that already ran 11% ahead of the prior year, yet still sat well below the $89.50 per pound spot price recorded on 21 August 2026.

The gap between what US utilities are paying under legacy contracts and what replacement material would cost at current spot prices is approximately 35%. That number converts supply concentration from a geopolitical concern into a direct balance-sheet risk for nuclear operators.

If Kazakhstani deliveries are disrupted or reduced, even partially, utilities must source replacement material at substantially higher prevailing market prices. The cost and production pressures described in the preceding sections, rising Kazatomprom costs, delayed infrastructure, and a smaller production envelope, are the mechanisms through which that disruption becomes more likely.

The shareholder vote on China and Russia contracts: what eastward reallocation means in practice

In a general meeting notice dated 21 August 2026, Kazatomprom put two uranium supply transactions to its shareholders for consideration, each of which would extend commercial ties with non-Western buyers:

• Contract 1: Spot-term uranium concentrate supply to SNURDC (China’s State Nuclear Uranium Resource Development Company), which handles procurement for China’s national nuclear programme.
• Contract 2: A supply arrangement with Uranium One Group JSC, a company connected to Russia’s Rosatom nuclear conglomerate.

Both transactions qualify as major or interested-party deals requiring shareholder approval under Kazakh corporate governance rules. The absentee ballot window opens approximately 22 September 2026 and closes 6 October 2026, with votes to be counted on or about 7 October 2026.

Volumes and pricing remain confidential. Kazatomprom has described terms as aligning with prevailing market conditions.

China and Russia nuclear supply agreements struck across 2025-2026 have established a pattern of preferential offtake arrangements with major producing nations, of which the pending Kazatomprom transactions with SNURDC and Uranium One are the latest examples, suggesting the eastward reallocation of uranium supply is a deliberate strategic programme rather than opportunistic deal-making.

A shrinking pool, split more ways

The commercial logic is straightforward even without knowing precise contract quantities. Kazatomprom has already cut its 2026 production guidance on a 100% basis from 32,777 tU to 27,500-29,000 tU, a reduction of approximately 10%. Attributable production guidance (the company’s ownership share) remains at 14,500-15,500 tU.

A 10% production cut, layered on top of new committed allocations directed toward Chinese and Russian counterparties, compresses the tonnage available to Western utilities from two sides at once. Any long-term volume committed to SNURDC and Uranium One mechanically shrinks the uncommitted pool available in spot and short-term markets where US utilities re-contract.

The 7 October vote result is not just a corporate governance milestone. It is the moment that converts the eastward reallocation risk from prospective to contractually committed. Whether those commitments are structured as take-or-pay obligations will determine how rigid the shift turns out to be.

Cumulative risk versus individually manageable factors: the analytical distinction that matters

Management’s stated positions should be represented clearly. Kazatomprom has characterised the TQZ delay as non-material to overall operations, described acid pricing as manageable, and confirmed that near-term supply contracts are in place.

None of those claims are unreasonable in isolation. The analytical case for elevated Western supply risk does not require disputing them.

It requires reading them together.

Individually, each of these factors is manageable. Collectively, they represent a structural shift in the reliability of Kazakhstani supply for Western nuclear utilities.

The MET tax increase is legislative and permanent in any reasonable planning timeframe. The eastward commercial reorientation, if approved, creates contractual commitments that are not easily reversed. The TQZ delay pattern, now on its third revision from three different causes, reflects a regulatory complexity that is a feature of the operating environment, not a one-time obstacle.

Sulfuric acid pricing and near-term supply coverage sit in a different category. These are cyclical, currently stable, and subject to management’s operational control.

The distinction gives you a lens for evaluating future Kazatomprom disclosures. The question is not “is this single development a crisis?” It is “does this development deepen or mitigate the compounding structural shift already underway?”

What US uranium investors and utilities should be watching next

Three near-term events will either resolve or deepen the key uncertainties:

1. 7 October 2026: shareholder vote count for the SNURDC and Uranium One contracts. This is the single most time-sensitive data point in this analysis. Any volume disclosures following approval will quantify the eastward reallocation for the first time.
2. Q3 2027 to Q1 2028: TQZ commissioning window. A third delay would confirm that Kazakh infrastructure projects carry a structural execution discount that Western counterparties need to price in permanently.
3. H2 2026 and full-year cost disclosures. Any further upward revision to C1 or AISC guidance will confirm whether the 13-percentage-point gap between cost inflation and spot price appreciation is widening or stabilising.

The standing metric is the price gap between what American utilities locked in under legacy agreements ($58.46 per pound in 2025) and the $89.50 per pound spot rate recorded on 21 August 2026, a differential of roughly 35%. If spot prices continue rising while utility contract prices reset more slowly, the cost of a Kazakh supply disruption grows with each passing quarter.

Uranium term price dynamics in 2026 reveal that the forward curve is pricing in a persistent supply deficit, which means the 35% gap between legacy US utility contract prices and current spot rates is unlikely to close through spot price correction alone; utilities that delay recontacting face a widening cost exposure.

As Kazakh supply reliability diminishes at the margin, producers aligned with Western markets acquire relative pricing power. Canada holds 32% of US utility supply and Australia 15%. Both represent jurisdictions where the regulatory, tax, and geopolitical risks that are compounding in Kazakhstan do not apply in the same way.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Forward-looking statements regarding production guidance, cost trajectories, and contract outcomes are subject to change based on market developments and company performance.

The case for reassessing Kazakhstan as a cornerstone of US uranium supply

The conditions that made Kazakhstan the reliable anchor of US uranium supply are no longer as durable as utility planners assumed. The evidence from H1 2026 does not point to imminent failure. It points to a supply chain undergoing a structural reorientation that has not yet been fully priced into Western procurement strategy.

The five compounding risk factors, taken together, tell a single story:

• Cost inflation is outpacing uranium price gains, compressing margins on every pound produced.
• Infrastructure delays at TQZ reveal a pattern of regulatory complexity, not a single recoverable setback.
• Eastward contract commitments, pending the October vote, would shift contracted volumes toward Chinese and Russian buyers, narrowing the pool of supply available to Western utilities.
• Production guidance cuts of approximately 10% shrink the total pool before reallocation even begins.
• US utility replacement-cost exposure of 35% above legacy contract prices quantifies the balance-sheet risk of disruption.

Revenue growth of 9% in H1 2026 is the headline figure that masks all of this. Kazatomprom equity deserves caution not because of any single factor, but because the cumulative evidence raises a question that utility financial planners and uranium investors need to answer directly: at what point does the compounding evidence justify accelerating procurement from Western-aligned suppliers, even at a cost premium?

For investors wanting a structured assessment of which domestic and allied-nation alternatives are realistically capable of replacing Kazakhstani tonnage at scale, our dedicated guide to US uranium supply security evaluates the production capacity gaps, permitting timelines, and strategic stockpile options that determine how quickly Western sourcing could absorb a material reduction in Kazakh deliveries.

Past performance does not guarantee future results. Financial projections are subject to market conditions and various risk factors.